Prepare for your visit
Peter J Abramson
Otolaryngology · Atlanta, GA · NPI 1003813379
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,537.70
in general payments reported to CMS, 2019-2025 · $915 in 2025
The $915 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Who reported paying
General payments only, top 6 by amount.
- Aerin Medical INC. $760.75
- Medtronic, INC. $728.91
- Genzyme Corporation $509.92
- Regeneron Healthcare Solutions, INC. $372.06
- Glaxosmithkline, LLC. $302.43
- Optinose US, INC. $177.07
Drugs and devices associated with these payments
Vivaer Stylus Rhinaer Stylus Stealthstation S8 Platform Dupixent Propel Nucala Botox Neffy Xhance Auvi-Q
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Peter Abramson listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/272285/peter-j-abramson